VANCOUVER, BC – TheNewswire – June 15, 2026 - In April 2026, MAPS Canada convened the first-ever National Dialogue on Access to Psychedelics, bringing together clinicians, researchers, policymakers, Indigenous knowledge holders, legal experts, community and business leaders, advocates, and people with lived experience to examine the future of psychedelic access in Canada.

The dialogue comes at a pivotal moment. Growing evidence supports the potential of psychedelic-assisted therapies for conditions including post-traumatic stress disorder (PTSD), depression, substance use disorders, and end-of-life distress. At the same time, public interest and demand for these treatments continue to increase - as do recent and upcoming legislative proposals signalling growing political attention to this emerging field.

Despite this momentum, access to psychedelic therapies in Canada remains limited and fragmented. Existing pathways are narrow, inconsistent, and often inaccessible to those who may benefit. Meanwhile, significant psychedelic use continues outside formal healthcare and regulatory systems.

Today, MAPS Canada released an Executive Summary highlighting key findings, priority areas, and calls to action emerging from the National Dialogue. The summary is intended to inform ongoing discussions and policy development ahead of the release of the full report.

“The National Dialogue made clear that Canadians are seeking safe, equitable access to psychedelic therapies. We now have an opportunity to move beyond fragmented pathways and work toward a more coordinated, evidence-informed approach.”

— Rielle Capler, Executive Director, MAPS Canada

Executive Summary: https://www.mapscanada.org/wp-content/uploads/2026/06/Executive-Summary_Toward-a-Framework-for-Psychedelic-Access_FINAL.pdf

Media Contact

Rielle Capler
Executive Director, MAPS Canada
rielle@mapscanada.org